[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622118":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":57,"collaborators":61,"id":63,"slug":10,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":75,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":82,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Tianjin Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Group Assignment",null,"Each subject receive a single intravenous injection of 11C\u002F18F-MET\u002FFET, and undergo PET\u002FCT imaging within the specificed time.",[13],"Diagnostic Test: 11C\u002F18F-MET\u002FFET",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","11C\u002F18F-MET\u002FFET","Each subject receive a single intravenous injection of 11C\u002F18F-MET\u002FFET, and undergo PET\u002FCT imaging within the specificed time",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Haonan Yu, MD","CONTACT","+8613821000597","dreamadam@126.com",[27,45],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"The First Affiliated Hospital of University of Science and Technology of China","RECRUITING","Hefei","Anhui","230000","China",{"type":35,"coordinates":36},"Point",[37,38],117.28083,31.86389,{"lat":38,"lon":37},[41],{"name":42,"role":23,"phone":43,"phoneExt":10,"email":44},"Qiang Xie, PhD","+8613721108043","ahxq1980@163.com",{"facility":46,"status":29,"city":47,"state":48,"zip":49,"country":33,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"Tianjin Medical University General Hospital","Tianjin","Tianjin Municipality","300052",{"type":35,"coordinates":51},[52,53],117.17667,39.14222,{"lat":53,"lon":52},[56],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Shaobo Yao, PhD","Prof.",[62],{"name":46,"class":6},"100622118",false,"NCT07379463","Amino Acid Transporter System PET\u002FCT Imaging in AATS-Related Diseases","Inclusion Criteria:\n\n1. adult patients (aged 18 years or order);\n2. patients with suspected or newly diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report);\n3. patients who had scheduled AATS PET\u002FCT scan;\n4. patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.\n\nExclusion Criteria:\n\n1. patients with non-malignant lesions;\n2. patients with pregnancy;\n3. the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.",true,"ALL","18 Years","90 Years",{"count":73,"type":74},500,"ESTIMATED","7 Days","OBSERVATIONAL","To evaluate the potential usefulness of 11C\u002F18F-MET\u002FFET positron emission tomography\u002F computed tomography (PET\u002FCT) for the diagnosis of primary and metastatic lesions in various amino acid transporter system (AATS)-related disease patients.",[79,80,81],"Amino-Acid Transport Disorder","Primary Hyperparathyroidism","Glioma",[83,84,85,86],"PET\u002FCT","Amino acid transporter","MET","FET","2026-01-23",{"date":89,"type":90},"2026-01-30","ACTUAL",{"date":92,"type":90},"2013-08-29",{"date":94,"type":74},"2033-08-29",{"name":5,"class":6},2]